English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To estimate the prognosis of AS in the current era, it is also essential to realize that the average age of AS patients has been getting higher as expected lifespan has been prolonged. A recent prospective population-based study demonstrated that the prevalence of AS in 50–59, 60–69, 70–79 and 80–89 year olds was 0.2, 1.3, 3.9 and 9.8%, respectively.2 Also, age-related he importance of estimating the prognosis of patients with aortic stenosis (AS) can not be emphasized too much. Today, aortic valve replacement (AVR) has been established as the standard therapy for symptomatic AS, but alternative therapies such as transcatheter aortic valve replacement (TAVR) are available for high-risk patients who are not eligible for open surgery. However, for the severest patients with a life expectancy <1 year or the chance of “survival with benefit” <25% at 2 years,1 TAVR is also not recommended. Recently, to overcome this clinical discrepancy, the balloon aortic valvuloplasty has been recovered its importance as a bridge therapy to the advanced therapy such as AVR or T

Estimating the Prognosis of Patients With Aortic Stenosis in the Current Japanese Population